G. Hasko et al., STIMULATION OF BETA-ADRENOCEPTORS INHIBITS ENDOTOXIN-INDUCED IL-12 PRODUCTION IN NORMAL AND IL-10 DEFICIENT MICE, Journal of neuroimmunology, 88(1-2), 1998, pp. 57-61
Stimulation of beta-adrenoceptors has been shown to regulate the produ
ction of various inflammatory mediators. In the present study, we inve
stigated in mice whether ligation of beta-adrenoceptors, modulates lip
opolysaccharide (LPS)-induced plasma levels of interleukin (IL)-12, in
terferon-gamma (IFN-gamma), and IL-10. In BALB/c mice, isoproterenol (
1-10 mg kg(-1), i.p.), a selective agonist of beta-adrenoceptors and a
lso dexamethasone (10 mg kg(-1), i.p.) pretreatment 30 min before the
administration of LPS suppressed plasma IL-12 (p40 and p70) concentrat
ions as determined at various time points after the LPS challenge. The
inhibition of IL-12 release by isoproterenol was prevented by the bet
a-adrenoceptor antagonist propranolol confirming the involvement of be
ta-adrenoceptors in the effect of isoproterenol. Furthermore, pretreat
ment of the animals with propranolol alone enhanced LPS-induced plasma
IL-12, suggesting that endogenous catecholamines inhibit IL-12 produc
tion via the beta-adrenoceptors. In IL-10 deficient C57BL/6 IL-10(-/-)
mice, plasma levels of IL-12 and IFN-gamma were significantly higher
than in their counterparts, with more than 70-fold increase in IL-12.
Furthermore, while augmenting the IL-10 response in C57BL/6 IL-10(+/+)
, isoproterenol inhibited the production of IL-12 in both the C57BL/6
IL-10(+/+) and C57BL/6 IL-10-/- mice, suggesting that the inhibition o
f IL-12 production by this compound is independent of the increased re
lease of IL-10. Our results demonstrate, for the first time, that stim
ulation of beta-adrenoceptors by isoproterenol or endogenous catechola
mines suppresses IL-12 production in vivo. (C) 1998 Elsevier Science B
.V. All rights reserved.